Business Description
McKesson Europe AG
ISIN : DE000CLS1001
Compare
Compare
Traded in other countries / regions
CLS1.Germany0OPB.UKCAKFY.USA IPO Date
2014-11-03Description
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 1.31 | |||||
| Interest Coverage | 1.98 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.39 | |||||
| Beneish M-Score | -3.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.4 | |||||
| 3-Year EBITDA Growth Rate | -7.8 | |||||
| 3-Year EPS without NRI Growth Rate | -5.5 | |||||
| 3-Year FCF Growth Rate | -84.2 | |||||
| 3-Year Book Growth Rate | 8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.82 | |||||
| Quick Ratio | 1.57 | |||||
| Days Inventory | 39.56 | |||||
| Days Sales Outstanding | 55.45 | |||||
| Days Payable | 91.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -6.44 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.68 | |||||
| Operating Margin % | 0.33 | |||||
| Net Margin % | -9.42 | |||||
| ROE % | -39.93 | |||||
| ROA % | -14.36 | |||||
| ROIC % | 1.15 | |||||
| ROC (Joel Greenblatt) % | -0.99 | |||||
| ROCE % | -0.66 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.54 | |||||
| PB Ratio | 1.99 | |||||
| Price-to-Free-Cash-Flow | 6100 | |||||
| Price-to-Operating-Cash-Flow | 6100 | |||||
| EV-to-EBIT | -262.1 | |||||
| EV-to-EBITDA | 36.64 | |||||
| EV-to-Revenue | 0.55 | |||||
| EV-to-FCF | 5707.99 | |||||
| Earnings Yield (Greenblatt) % | -0.38 | |||||
| FCF Yield % | 0.02 | |||||
| Forward Rate of Return (Yacktman) % | -10.75 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers